Plozasiran

Redemplo

25 MG / 0.5 ML SolutionCanadaMarketedAuthorised 2 Jul 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Redemplo 25 MG Solucion Inyectable en Jeringa PrecargadaSpain · 25 mg · solución inyectable en jeringa precargada · Arrowhead Pharmaceuticals Ireland LimitedSame brand
RedemploEuropean Union · Arrowhead Pharmaceuticals Ireland LimitedSame brand
Redemplo 25 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Arrowhead Pharmaceuticals Ireland LimitedSame brand
RedemploUnited States · 25MG BASE/0.5ML · solution · ArrowheadSame brand

Documents

The official texts, at the regulator.

Register entryHealth Canada

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Plozasiran

Redemplo

25 MG / 0.5 ML SolutionCanadaMarketedAuthorised 2 Jul 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Register entryHealth Canada

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Plozasiran
Strength: 25 MG / 0.5 ML
Dosage form: Solution
Route: Subcutaneous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 2 Jul 2026
Registration: DIN 02564327
Marketing authorisation holder: Arrowhead Pharmaceuticals, INC.
ATC code: C10AX
Group: Cardiovascular system
Supply: PRESCRIPTION